A mindfulness meditation app for teenagers with moderate to severe atopic dermatitis
Tests a mindfulness meditation app in teenagers with moderate to severe atopic dermatitis.
Plain-language title generated from the registry record
Registry title: Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
Key facts
- Where
- New York, United StatesSee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 13 and 17 years old?
Source: NCT07746427, who can take part
Where in United States
- Columbia University Irving Medical CenterNew York, United StatesTaking people
- Weill Cornell MedicineNew York, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Weill Medical College of Cornell University
- Trial code
- NCT07746427
- Record updated
- 23 October 2026
- Original description
Atopic dermatitis is well reported to have a significant impact on well-being in adolescents with atopic dermatitis, without clear recommendations for intervention. The investigators aim to identify an accessible, effective digital health intervention for these patients. The investigators hypothesize that regular use of a digital mindfulness meditation app will improve disease control and quality of life in adolescents with moderate to severe atopic dermatitis based on validated survey measures.Read full original descriptionShow less
Outcomes of a Digital Mindfulness Meditation App-Based Intervention in Adolescents With Moderate to Severe Atopic Dermatitis (MIND-AD)
Atopic dermatitis is well reported to have a significant impact on well-being in adolescents with atopic dermatitis, without clear recommendations for intervention. The investigators aim to identify an accessible, effective digital health intervention for these patients. The investigators hypothesize that regular use of a digital mindfulness meditation app will improve disease control and quality of life in adolescents with moderate to severe atopic dermatitis based on validated survey measures.
Inclusion: Adolescents age 13-17 years; Atopic dermatitis refractory to standard topical treatment including topical steroids or topical calcineurin inhibitors; Moderate to severe atopic dermatitis via PO-SCORAD score on enrollment.
Exclusion: Started on a biologic agent (i.e. dupxient) within the past 3 months; Mild atopic dermatitis via PO-SCORAD score on enrollment.